In a bid to increase access to COVID-19 testing and bolster domestic manufacturing of the tests, President Joe Biden’s administration, through the U.S. Department of Health and Human Services, will invest $650 million from the American Rescue Plan to strengthen manufacturing capacity for quick diagnostic testing through rapid point-of-care molecular tests.
Biden Administration invests $650 million in rapid diagnostic testing
